1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Egypt Pharmaceuticals and Healthcare Report Q4 2016

Egypt Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 93 pages

Includes 3 FREE quarterly updates



BMI View:
Egypt's pharmaceutical and healthcare sector presents a high-risk investment opportunity forinternational drugmakers. The North African country continues to attract a significant deal of attentionfrom multinational pharmaceutical companies looking to take advantage of the rapidly growing populationand policy reforms. However, the economic recovery and political situation will remain highly influentialfactors determining company interest in Egypt.

Headline Expenditure Projections


- Pharmaceuticals: EGP33.08bn (USD4.29bn) in 2015 to EGP35.60bn (USD4.09bn) in 2016; +7.6% inlocal currency terms and -4.7% in US dollar terms. Forecast revised down from Q316.

- Healthcare: EGP125.86bn (USD16.34bn) in 2015 to EGP137.21bn (USD15.77bn) in 2016; +9.0% inlocal currency terms and -3.5% in US dollar terms. Forecast revised down from Q316.

Table Of Contents

Egypt Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Egypt 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Egypt 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Egypt 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 25
Egypt OTC Drug Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Egypt 2012-2020) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Egypt 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Egypt 2014-2020) 32
Industry Risk Reward Index 33
Middle East and Africa Risk/Reward Index - Q4 2016 33
Egypt Risk/Reward Index 41
Rewards 41
Risks 42
Regulatory Review 43
Intellectual Property Issues 43
Pricing Regime 46
Market Overview 49
Healthcare Sector 50
Table: Healthcare Resources (Egypt 2010-2015) 54
Table: Healthcare Personnel (Egypt 2010-2015) 54
Table: Healthcare Activity (Egypt 2010-2015) 55
Research and Development 55
Clinical Trials 56
Epidemiology 57
Competitive Landscape 62
Research-Based Industry 62
Table: Multinational Market Activity 65
Generic Drugmakers 66
Pharmaceutical Distribution 66
Pharmaceutical Retail Sector 67
Company Profile 68
Amoun Pharmaceutical Company (APC) 68
Egyptian International Pharmaceutical Industries Co (EIPICO) 71
Medical Union Pharmaceuticals (MUP) 75
South Egyptian Drug Industries (SEDICO) 77
VACSERA 80
Demographic Forecast 82
Demographic Outlook 82
Table: Population Headline Indicators (Egypt 1990-2025) 83
Table: Key Population Ratios (Egypt 1990-2025) 83
Table: Urban/Rural Population and Life Expectancy (Egypt 1990-2025) 84
Table: Population By Age Group (Egypt 1990-2025) 84
Table: Population By Age Group % (Egypt 1990-2025) 85
Glossary 87
Methodology 89
Pharmaceutical Expenditure Forecast Model 89
Healthcare Expenditure Forecast Model 89
Notes On Methodology 90
Risk/Reward Index Methodology 91
Index Overview 92
Table: Pharmaceutical Risk/Reward Index Indicators 92
Indicator Weightings 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.